Please assess the completion status of the following clinical trial:

Trial Title: Post-operative Radiotherapy With Cisplatin Alone or in Combination With Iressa in Upper Aerodigestive Tract Carcinomas

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with upper aerodigestive tract carcinomas (all sites included) having surgical resection and eligible for post-operative radiation + cisplatin.~* Patient having a tumoral biopsy (0.5 - 1 cm3) stored in liquid nitrogen at time of surgical resection (patients with small tumors located in larynx for instance will not be included)~* Patients receiving post-operative radiation (\>=60 Gy on tumor bed and/or cervical area), associated with cisplatin, 6 weeks after surgery at the latest.~Exclusion Criteria:~* previous history of cancer (except skin basal cell carcinoma)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- postop chemoradio with cisplatin (Type: ACTIVE_COMPARATOR): postoperative chemoradiotherapy with cisplatin
- postop chemoradio (cisplatin)+gefitinib (Type: EXPERIMENTAL): postoperative chemoradiotherapy with cisplatin + gefitinib

Based on this trial design, predict the completion outcome and termination type (if applicable).